Zobrazeno 1 - 10
of 84
pro vyhledávání: '"Joseph Kerger"'
Publikováno v:
Case Reports in Oncology, Vol 16, Iss 1, Pp 1183-1195 (2023)
Cutaneous melanoma can metastasize to almost any organ, including in-transit metastases, lymph nodes, liver, lungs, brain, and bones. Spread to the gastrointestinal tract is less common and generally concerns the small bowel, colon, and stomach. Gall
Externí odkaz:
https://doaj.org/article/e280f4b4b2834a10ad5a631a5ccf6a89
Autor:
Mohammad Krayem, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, Joseph Kerger, Ahmad Awada, Fabrice Journe, Ghanem E. Ghanem
Publikováno v:
Cancers, Vol 16, Iss 14, p 2587 (2024)
In the original article [...]
Externí odkaz:
https://doaj.org/article/f8ee283d7a7c4460823836a35798ff99
Autor:
Xiaoxiao Wang, Mariano Suppa, Pascal Bruderer, Nicolas Sirtaine, Sandrine Aspeslagh, Joseph Kerger
Publikováno v:
Case Reports in Oncology, Vol 14, Iss 2, Pp 861-867 (2021)
Immunotherapy has become the standard of care for various cancer types. The widespread use of immune checkpoints inhibitors confronts us with a whole range of novel immune-related adverse events. Skin toxicity is one of the most frequent adverse even
Externí odkaz:
https://doaj.org/article/3280a41923814899bf38a75cb45ffaa1
Autor:
Karim Gourari, Julien Catherine, Soizic Garaud, Joseph Kerger, Antonia Lepida, Aspasia Georgala, Fabienne Lebrun, Maria Gomez Galdon, Thierry Gil, Karen Willard-Gallo, Mireille Langouo Fontsa
Publikováno v:
Diagnostics, Vol 12, Iss 2, p 539 (2022)
Tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors (ICIs) significantly improve the outcomes of patients with advanced clear cell renal cell carcinoma (ccRCC); however, high-grade toxicities can occur, particularly during combination
Externí odkaz:
https://doaj.org/article/8bf09445348c40b79fe9eebf7616680f
Autor:
Piotr Rutkowski, Patrick Pauwels, Joseph Kerger, Bart Jacobs, Geert Maertens, Valerie Gadeyne, Anne Thielemans, Katrien de Backer, Bart Neyns
Publikováno v:
Cancers, Vol 13, Iss 14, p 3591 (2021)
Tissue-based tests for BRAFV600 mutation-positive melanoma involve invasive biopsy procedures, and can lead to an erroneous diagnosis when the tumor samples degrade. Herein, we explored a minimally invasive, cell-free deoxyribonucleic acid (cfDNA)-ba
Externí odkaz:
https://doaj.org/article/24f9a23e43244cfab362f87bf433b3cd
Publikováno v:
Chinese Journal of Cancer, Vol 36, Iss 1, Pp 1-5 (2017)
Abstract Metastatic melanoma has long been considered to have a very poor prognosis and to be chemo-resistant. However, a subgroup of patients with metastatic melanoma presents remarkable responses to chemotherapeutic agents, even in the absence of a
Externí odkaz:
https://doaj.org/article/c49a2630e0a547a0bcffda8aac1e601e
Autor:
Mohammad Krayem, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, Joseph Kerger, Ahmad Awada, Fabrice Journe, Ghanem E. Ghanem
Publikováno v:
Cancers, Vol 12, Iss 10, p 2981 (2020)
The authors would like to make a correction to their published paper [...]
Externí odkaz:
https://doaj.org/article/8204075162574d93b3ce613046da7423
Autor:
Celeste Lebbé, Caroline Dutriaux, Thierry Lesimple, Willem Kruit, Joseph Kerger, Luc Thomas, Bernard Guillot, Filippo de Braud, Claus Garbe, Jean-Jacques Grob, Carmen Loquai, Virginia Ferraresi, Caroline Robert, Paul Vasey, Robert Conry, Richard Isaacs, Enrique Espinosa, Armin Schueler, Giorgio Massimini, Brigitte Dréno
Publikováno v:
Cancers, Vol 12, Iss 7, p 1727 (2020)
This study investigated the efficacy and safety of pimasertib (MEK1/MEK2 inhibitor) versus dacarbazine (DTIC) in patients with untreated NRAS-mutated melanoma. Phase II, multicenter, open-label trial. Patients with unresectable, stage IIIc/IVM1 NRAS-
Externí odkaz:
https://doaj.org/article/fb6a7c3b4d9c40bfbbb29e6cefdef71c
Autor:
Mohamad Krayem, Philippe Aftimos, Ahmad Najem, Tim van den Hooven, Adriënne van den Berg, Liesbeth Hovestad-Bijl, Rik de Wijn, Riet Hilhorst, Rob Ruijtenbeek, Malak Sabbah, Joseph Kerger, Ahmad Awada, Fabrice Journe, Ghanem E. Ghanem
Publikováno v:
Cancers, Vol 12, Iss 2, p 512 (2020)
Mitogen-activated protein kinase (MAPK) inhibition with the combination of BRAF (Rapidly Accelerated Fibrosarcoma) and MEK (Mitogen-activated protein kinase kinase) inhibitors has become the standard of first-line therapy of metastatic melanoma harbo
Externí odkaz:
https://doaj.org/article/03e5f2913507482d86d31eade456925c
Autor:
Denis Larsimont, Marie Chintinne, Joseph Kerger, Laura Polastro, Jean-Marie Nogaret, Michel Moreau, C.F. Pop, Isabelle Veys, Gabriel Liberale
Publikováno v:
Journal of Visceral Surgery
Introduction: Cytoreductive surgery of locally advanced ovarian cancer has evolved in the last few years from surgery to remove macroscopic residual disease (< 1 cm; R2b) to macroscopic complete cytoreductive surgery with no gross residual disease (R